In view of its ambivalent role as a tumor suppressor and oncogenic factor and the numerous alterations affecting this role, IKAROS can be considered a possible key driver in the pathogenesis of ALL as well as AML. This evidence concerns the gene IKZF1 and acute myeloid leukemia.